← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Beth Israel Deaconess Medical Center, Inc.
$101,579,180
Total funding
121
Grants
Funding over time
peak $16.9M · FY2008–25$20M$15M$10M$5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$97,440,495 · 112
NASA$4,138,685 · 9
By mechanism
—$101,579,180 · 121
Investigators at Beth Israel Deaconess Medical Center, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
DAMP-MEDIATED INNATE IMMUNE FAILURE AND PNEUMONIA AFTER TRAUMA$10,000,000
· FY2016 · Defense Health Agency
ARYL HYDROCARBON RECEPTOR INNATE IMMUNE MODULATORS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE$6,766,843
· FY2021 · Defense Health Agency
DEVELOPMENT OF COMPLETEMENT INHIBITORS TO LIMIT TISSUE AS ADJUVANTS TO RESUSCITATION$3,115,384
· FY2008 · Department of Defense
TRANSCRIPTION FACTORS AS THERAPEUTIC TARGETS IN FOCAL SEGMENTAL GLOMERULAR SCLEROSIS$2,455,660
· FY2022 · Department of the Army
DEFINING INTRAGLOMERULAR MECHANICAL STRESSES AND PODOCYTE RESPONSE IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS$2,155,903
· FY2022 · Defense Health Agency
DEVELOPMENT OF ULTRASOUND TO MEASURE IN-VEVO DYNAMIC CERVICAL SPINE INTERVERTEBRAL DISC MECHANICS$2,139,428
· FY2013 · Department of Defense
"COMPLEMENT AND IMMUNOREGULATION IN TISUSUE INJURY"$2,114,127
· FY2012 · Department of the Army
APOL1-ASSOCIATED FSGS: GENETICS AND MECHANISMS$2,095,170
· FY2020 · Defense Health Agency
VACCINATION WITH DENDRITIC CELL MYELOMA FUSIONS IN CONJUNCTION WITH STEM CELL TRANSPLANTATION AND PD-1 BLOCKADE$2,043,308
· FY2009 · Department of Defense
CONFIRMING THE EFFECTIVENESS OF ACUPUNCTURE TO TREAT THE SYMPTOMS OF GULF WAR ILLNESS$1,994,937
· FY2025 · Defense Health Agency
SUPPRESSION OF BARRIER ANTIMICROBIAL DEFENSES BY TRAUMA$1,991,326
· FY2024 · Defense Health Agency
"COMPLEMENT ACTIVATION ALTERS PLATELET FUNCTION"$1,902,558
· FY2012 · Department of the Army
DEVELOPMENT OF PRECISION NEOADJUVANT-ADJUVANT THERAPIES$1,840,716
· FY2016 · Department of the Army
DYSREGULATED SIGNALING IN CROHN'S DISEASE$1,818,075
· FY2016 · Department of the Army
PLATELETS, COMLEMENT AND COAGULATION IN TRAUMA$1,769,849
· FY2009 · Department of the Army
STRAIN-PROGRAMMABLE BIOADHESIVE PATCH FOR ACCELERATED HEALING FOR DIABETIC ULCER$1,729,921
· FY2021 · Defense Health Agency
TARGETING SPECIFIC LNCRNAS IN NOVEL COMBINED THERAPIES TO MODULATE THE TSP1-DEPENDENT IMMUNE MICROENVIRONMENT VULNERABILITIES IN ADVANCED THYROID CANCER$1,723,552
· FY2025 · Defense Health Agency
DRUG INHIBITION OF KCA3.1 CHANNEL KCNN4 AS A STRATEGY TO RETARD CYST GROWTH AND DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE$1,623,750
· FY2018 · Department of the Army
USING AFFINITY-BASED PROTEOMICS TO IDENTIFY DIAGNOSTIC AND PLASMA BIOMARKERS FOR ENDOMETRIOSIS$1,472,315
· FY2019 · Defense Health Agency
DISCOVERY OF NOVEL TARGETS TO LIMIT TISSUE INJURY$1,467,956
· FY2009 · Department of Defense